CTRI/2024/03/063481
Not Yet Recruiting
Phase 3
Efficacy and Safety of Anticoagulation in patients with Digital Gangrene and an underlying Connective Tissue Disease - NI
Department of Clinical Immunology & Rheumatology0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: M339- Dermatopolymyositis, unspecifiedHealth Condition 2: M319- Necrotizing vasculopathy, unspecifiedHealth Condition 3: M340- Progressive systemic sclerosisHealth Condition 4: M368- Systemic disorders of connective tissue in other diseases classified elsewhereHealth Condition 5: M359- Systemic involvement of connectivetissue, unspecifiedHealth Condition 6: M321- Systemic lupus erythematosus withorgan or system involvement
- Sponsor
- Department of Clinical Immunology & Rheumatology
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients with digital gangrene of duration less than or equal to 1 month, defined as bluish blackish
- •discoloration of any digit, including pre\-gangrenous changes in the form of intense pain, pallor
- •and/or dusky colour change of digits and delayed capillary refill time.
- •2\. Patients with a diagnosis of Connective tissue disorder (CTD) as per latest standard
- •diagnostic/classification criteria
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Efficacy and safety of anticoagulant treatment using new alternative antithrombotic agents in acute cardioembolic stroke with nonvalvular atrial fibrillation.cerebral infarctionJPRN-UMIN000010477Department of Neurology, Kansai Medical University50
Recruiting
N/A
Efficacy and safety of anticoagulant treatment using New oral anticoagulant (edoxaban) in atrial fibrillation after cardiac surgery.arterial fibrillation after cardiac surgery (nonvalvular disease)JPRN-UMIN000021138ihon University school of medicine150
Not Yet Recruiting
N/A
The efficacy and safety of anticoagulant therapy Arixtra Injection for the prevention of the vein thromboembolism in laparoscopic colorectal surgerycolorectal cancerJPRN-UMIN000007005Osaka Medical College200
Completed
N/A
The Efficacy of Pro- and Anticoagulant Therapy in Plasma of Patients with Cirrhosis undergoing Orthotopic Liver TransplantatiobleedingThrombosis100196541000318410014523NL-OMON42693niversitair Medisch Centrum Groningen60
Completed
N/A
A Study of Safety and efficacy of anticoagulant therapy in the treatment of Atrial Fibrillation in KANAGAWAAtrial fibrillationJPRN-UMIN000011830ASSAF-K steering committee5,000